Artículo de revista
Sinoviortesis con radioisótopos en hemofilia: Experiencia de un centro en Chile
Fecha
2019Registro en:
Revista Médica de Chile, Volumen 147, Issue 5, 2019, Pages 568-573
07176163
00349887
10.4067/S0034-98872019000500568
Autor
Soto, Verónica
Morales, María Mercedes
Morales, Patricio
Oyarzún, Andrés
Cortez, Daniela
González, Macarena
Institución
Resumen
Background: In patients with hemophilia, radionuclide synoviorthesis, or the
intra-articular injection of a radionuclide to decrease the synovial hypertrophy
tissue, aims to decrease or avoid hemarthrosis. Aim: To evaluate the effectiveness
of radionuclide synoviorthesis in hemophilia. Material and Methods: Observational
retrospective study of the evolution of 107 male patients aged 3 to 54
years who were subjected to radionuclide synoviorthesis between 2007 and 2015.
Results: Of 164 treated joints, in 65% treatment was successful, (defined as zero
to two hemarthroses and absence of synovitis during the follow up period), in 17%
it was partially successful (defined as two or less hemarthroses, but persistence of
the synovitis) and failed in 18% of the procedures. No important complications
were recorded. Conclusions: Radionuclide synoviorthesis has an overall 82%
success rate, is minimally invasive, can be used at any age and is inexpensive
We recommend its implementation in Chilean hemophilia treatment centers.